|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
V.I. Kudinov, M.S. Nichitenko, A.I. Chesnikova
THERAPY WITH LIRAGLUTIDE SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL AND HAS POSITIVE IMPACT ON THE CARDIOVASCULAR SYSTEM OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS
|
№16 / 2013
|
|
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
M.E. Statsenko, M.V. Derevyanchenko
FEATURES OF MANAGEMENT OF HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A VIEW OF CARDIOLOGIST
|
№16 / 2013
|
|
N.A. Chernikova 1, A.S. Ametov 1, M.B. Antsiferov 2
BASAL INSULIN THERAPY: EXPERIENCE IN CLINICAL PRACTICE
|
№16 / 2013
|
|
E.A. Ushkalova
NEW CLASS OF ANTIDIABETIC DRUGS - SODIUM- GLUCOSE COTRANSPORTER INHIBITORS
|
№16 / 2013
|
|
N.A. Chernikova 1, M.B. Antsiferov 2
ROLE AND PLACE OF HYPOGLYCEMIA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
E.V. Biryukova, T.B. Danilova
EFFICACY AND SAFETY OF GLYCAEMIC CONTROL USING DIABETON MR: PREREQUISITE FOR SUCCESSFUL PREVENTION OF CHRONIC COMPLICATIONS OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
I.Yu.Demidova, V. V. Boeva
EARLY DIAGNOSIS AND TREATMENT OF IMPAIRED FASTING GLUCOSE REDUCES RATE OF ITS CONVERSION TO IMPAIRED GLUCOSE TOLERANCE AND TYPE 2 DIABETES MELLITUS
|
№10 / 2013
|
|
I.Yu.Demidova
The Clinical Advantages Of The First Human Glp-1 Analogue Liraglutide In The Treatment Of Patients With Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
N.A. Petunina, L.V. Trukhina, E.I. Sinitsina, M.B. Antsiferov
Benefits Of Long-acting Metformin
|
№5 / 2013
|
Русский
